2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee

J Am Coll Cardiol. 2021 Feb 9;77(5):629-658. doi: 10.1016/j.jacc.2020.09.011. Epub 2020 Nov 26.
No abstract available

Keywords: ACC Expert Consensus Decision Pathway; DOAC; anticoagulant therapy; antiplatelet therapy; atherosclerotic cardiovascular disease; atrial fibrillation; percutaneous coronary intervention; venous thromboembolism.

Publication types

  • Practice Guideline

MeSH terms

  • Atrial Fibrillation / complications
  • Atrial Fibrillation / therapy*
  • Cardiology*
  • Cardiovascular Diseases / therapy
  • Consensus*
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors
  • Societies, Medical*
  • United States
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control*

Substances

  • Platelet Aggregation Inhibitors